Yahoo · Sep 28, 2026
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
NRC's rising recurring contract value, expanding sales pipeline and AI-enabled tools support revenue visibility and potential margin improvement.
NYSE · NRC
Healthcare · Medical - Healthcare Information Services
$21.19
Up+$0.14 (+0.67%)
Updated Oct 1, 2026, 11:22 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NRC
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 30, 2026
NRC closed at $21.19 after 20 trading sessions, up 5.90% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 30, 2026 | $21.10 | $21.56 | $20.68 | $21.19 | 142.65K |
| Sep 29, 2026 | $19.915 | $21.08 | $19.775 | $21.05 | 135.9K |
| Sep 28, 2026 | $19.36 | $20.145 | $19.1801 | $20.06 | 83.32K |
| Sep 25, 2026 | $20.23 | $20.28 | $19.55 | $19.57 | 139.18K |
| Sep 24, 2026 | $21.41 | $21.7688 | $20.09 | $20.35 | 112.63K |
| Sep 23, 2026 | $21.81 | $21.9591 | $21.3601 | $21.57 | 105.98K |
| Sep 22, 2026 | $21.32 | $21.93 | $21.32 | $21.86 | 131.04K |
| Sep 21, 2026 | $20.58 | $21.89 | $20.43 | $21.27 | 158.55K |
| Sep 18, 2026 | $20.87 | $21.17 | $20.4401 | $20.56 | 360.43K |
| Sep 17, 2026 | $22.36 | $22.36 | $20.84 | $20.87 | 88.17K |
| Sep 16, 2026 | $21.88 | $22.24 | $21.88 | $22.05 | 72.07K |
| Sep 15, 2026 | $22.31 | $22.33 | $21.90 | $21.96 | 105.03K |
| Sep 14, 2026 | $21.21 | $22.34 | $21.00 | $22.31 | 92.57K |
| Sep 11, 2026 | $21.53 | $21.53 | $20.73 | $21.12 | 94.31K |
| Sep 10, 2026 | $20.95 | $21.41 | $20.84 | $21.26 | 108.63K |
| Sep 9, 2026 | $21.08 | $21.26 | $20.75 | $20.93 | 134.69K |
| Sep 8, 2026 | $21.40 | $21.605 | $20.80 | $21.19 | 144.67K |
| Sep 4, 2026 | $20.99 | $21.67 | $20.80 | $21.53 | 141.62K |
| Sep 3, 2026 | $20.22 | $21.58 | $20.22 | $21.25 | 168.25K |
| Sep 2, 2026 | $20.47 | $20.65 | $19.925 | $20.01 | 114.05K |
The latest Smart Investors Daily articles mentioning NRC.
Company
Market Activity
Research & News
NRC research
Company profile and research snapshot.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 29, 2026 | Citizens | Market Outperform | — |
| Jun 22, 2026 | Citizens | Market Outperform | — |
No generated briefing is available yet.
Yahoo · Sep 28, 2026
NRC's rising recurring contract value, expanding sales pipeline and AI-enabled tools support revenue visibility and potential margin improvement.
Yahoo · Sep 25, 2026
NRC Health (NASDAQ:NRC) recently announced a total dividend of $0.16 per share, with the ex-dividend date set for 2026-09-25. This includes a $0.16 per share cash dividend payable on 2026-10-09. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.
Yahoo · Sep 21, 2026
LINCOLN, Neb., September 21, 2026--The Governance Institute (TGI), a service of NRC Health, today released The Governance Advantage: Four Considerations for Hospital and Health System Board Assessment, a new report from its Blue Ribbon Committee on Hospital and Health System Board Assessment that identifies four considerations for boards to incorporate into their next assessment and current development efforts.
Yahoo · Sep 2, 2026
LINCOLN, Neb., September 02, 2026--Healthcare leaders are under growing pressure to improve patient experience, support care teams, strengthen safety, and act on feedback faster. A new KLAS Research First Look report shows NRC Health Rounding received a 91.6 Overall Performance Score, as measured by KLAS, providing early insight into how healthcare leaders are using the solution.*
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NRC.